PDCD1 and neoplasm: The resulting PD-1-deficient CD133-specific CAR T cells showed improved proliferation, cytokine secretion, and cytotoxicity in vitro (U251 CD133-OE luc cells) and enhanced tumor growth inhibition in an orthotopic mouse model of glioma, compared to conventional CD133-CAR T cells.